Influenza News and Research

Latest Influenza News and Research

An estimated 15% of U.S. adults infected with SARS-CoV-2 have long-COVID

In a recent study published in the journal JAMA Network Open, researchers in the United States estimated the sociodemographic factors associated with and prevalence of post-acute coronavirus disease 2019 (COVID-19) symptom sequelae (PASC) or long COVID (LCOVID).

30 Oct 2022

Study reports on a novel property of antibodies, light chain coherence

Researchers investigate whether pairs of unrelated B-cells that have similar heavy chains also have the same light chains.

30 Oct 2022

New insights on antibody response against SARS-CoV-2 Omiron sublineages

Knowing how well vaccination against one SARS-CoV-2 strain (with or without previous infection) counteracts infection with a different strain is a critical research question.

28 Oct 2022

The impact of seasonal coronavirus immunity on susceptibility to SARS-CoV-2 infection and COVID-19 vaccination

Researchers investigated whether immunity against seasonal human coronavirus spike proteins of HKU1, OC43, NL63, or 229E could protect against SARS-CoV-2 in vitro.

28 Oct 2022

In mild cases of COVID, blood clot risk is higher

Researchers examine the association between COVID-19 and increased cardiovascular outcomes and mortality sequelae.

27 Oct 2022

Third dose of COVID-19 mRNA vaccine offers cirrhosis patients strong protection against the virus

Cirrhosis of the liver is associated with decreased responsiveness to many vaccines, including those that protect against COVID-19.

27 Oct 2022

Rare variants of type I IFN immunity genes could underlie life-threatening COVID-19

Researchers assessed whether loss-of-function variants of type I interferon immunity genes are associated with life-threatening COVID-19.

27 Oct 2022

Vaccination- and/or natural infection-induced immune responses against SARS-CoV-2 Omicron subvariants

Researchers comparatively evaluated the neutralization antibody titers for SARS-CoV-2 Omicron VOC subvariants BA.1, BA.2, BA.4/5 among individuals with ancestral B.1 strain infections, vaccinated individuals, or with hybrid immunity from breakthrough infections and vaccinations with Delta or Gamma VOCs.

27 Oct 2022

Study reveals conserved and divergent host responses to infections with SARS-CoV-2 variants of concern

Researchers analyzed the phenotypes of the SARS-CoV-2 variants of concern (VOCs), the molecular responses to infections from these VOCs, and the evolving virus-host interactions using a comparative genomic and proteomic approach.

26 Oct 2022

SARS-CoV-2 BQ.1 variant cases may increase in Europe

A recent epidemiological update by the European Center for Disease Prevention and Control indicated that a new SARS-CoV-2 Omicron sublineage was likely to increase COVID-19 case numbers.

26 Oct 2022

A review of emerging pediatric respiratory viruses

Respiratory viruses continue to be a leading cause of childhood morbidity and mortality.

26 Oct 2022

Did COVID-19 mitigation measures in the United Kingdom impact the transmission of other infectious diseases?

Researchers explored the impact of the coronavirus disease 2019 (COVID-19) pandemic-associated non-pharmaceutical prevention measures on the transmission of 22 infectious diseases in England.

25 Oct 2022

Avian influenza virus introduced from Europe to North America through Iceland

A new study indicated that Iceland was the stepping stone for the translocation of the highly pathogenic avian influenza virus (HPAIV) between North America and Europe.

25 Oct 2022

Researchers design a COVID-19 vaccine construct using hybrid SARS-CoV-2 spike protein and nucleocapsid protein peptides

Researchers designed a COVID-19 vaccine construct using hybrid SARS-CoV-2 S protein (containing SARS-CoV-2 Delta and Omicron variant mutations) and N protein peptides that confer T lymphocyte-mediated immune protection.

25 Oct 2022

What is the efficacy of mulberry component Kuwanon C against COVID-19?

A recent study determined the underlying antiviral mechanism of KC associated with the inhibition of SARS-CoV-2.

24 Oct 2022

A study of Moderna's COVID vaccine in children aged 6 months to 5 years

In a recent study published in the New England Journal of Medicine, researchers presented the findings of the ongoing KidCOVE trial in the United States (US).

23 Oct 2022

FebriDX point-of-care immunoassay can rapidly determine if an infection is bacterial or viral

Researchers explore whether FebriDx could differentiate between bacteria- and virus-induced immune responses during acute respiratory infection.

23 Oct 2022

Regenstrief Institute and Indiana Department of Health partner on an influenza surveillance data pilot study

Regenstrief Institute and the Indiana Department of Health are collaborating on an influenza surveillance data pilot study to provide in-depth data and analysis of the spread of Influenza in Indiana, similar to how Regenstrief has provided data on COVID-19.

20 Oct 2022

Racial, ethnic disparities found in flu vaccination coverage and hospitalization rates

Black, Hispanic, and American Indian/Alaska Native (AI/AN) adults in the United States are more likely to be hospitalized with flu, as well as less likely to be vaccinated against flu, according to a new CDC Vital Signs report.

20 Oct 2022

Differential effects of SARS-CoV-2 variants on children and adolescents

A recent Emerging Infectious Diseases journal study evaluated whether specific SARS-CoV-2 variants were linked with different clinical manifestations in children and adolescents.

19 Oct 2022

Influenza News and Research

Latest Influenza News and Research

An estimated 15% of U.S. adults infected with SARS-CoV-2 have long-COVID

Study reports on a novel property of antibodies, light chain coherence

New insights on antibody response against SARS-CoV-2 Omiron sublineages

The impact of seasonal coronavirus immunity on susceptibility to SARS-CoV-2 infection and COVID-19 vaccination

In mild cases of COVID, blood clot risk is higher

Third dose of COVID-19 mRNA vaccine offers cirrhosis patients strong protection against the virus

Rare variants of type I IFN immunity genes could underlie life-threatening COVID-19

Vaccination- and/or natural infection-induced immune responses against SARS-CoV-2 Omicron subvariants

Study reveals conserved and divergent host responses to infections with SARS-CoV-2 variants of concern

SARS-CoV-2 BQ.1 variant cases may increase in Europe

A review of emerging pediatric respiratory viruses

Did COVID-19 mitigation measures in the United Kingdom impact the transmission of other infectious diseases?

Avian influenza virus introduced from Europe to North America through Iceland

Researchers design a COVID-19 vaccine construct using hybrid SARS-CoV-2 spike protein and nucleocapsid protein peptides

What is the efficacy of mulberry component Kuwanon C against COVID-19?

A study of Moderna's COVID vaccine in children aged 6 months to 5 years

FebriDX point-of-care immunoassay can rapidly determine if an infection is bacterial or viral

Regenstrief Institute and Indiana Department of Health partner on an influenza surveillance data pilot study

Racial, ethnic disparities found in flu vaccination coverage and hospitalization rates

Differential effects of SARS-CoV-2 variants on children and adolescents

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Shaping the future of lab automation through AI and robotics

Influenza News and Research

Latest Influenza News and Research

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Shaping the future of lab automation through AI and robotics

Newsletters you may be interested in